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Bietti crystalline corneoretinal dystrophy (BCD) is an autosomal recessive retinal degeneration characterized by
multiple glistening intraretinal dots scattered over the fundus, degeneration of the retina, and sclerosis of the
choroidal vessels, ultimately resulting in progressive night blindness and constriction of the visual field. Although
BCD has been associated with abnormalities in fatty-acid metabolism and absence of fatty-acid binding by two
cytosolic proteins, the genetic basis of BCD is unknown. We report linkage of the BCD locus to D4S426 (maximum
LOD score [Zmax] 4.81; recombination fraction [v] 0), D4S2688 ( ; ), and D4S2299 (Z p 3.97 vp 0 Z pmax max
; ), on chromosome 4q35-4qtel. Multipoint analysis confirmed linkage to the region telomeric of D4S16525.31 vp 0
with a Zmax of 5.3 located 4 cM telomeric of marker D4S2930.
Bietti crystalline corneoretinal dystrophy (BCD [MIM
210370]) is a form of autosomal recessive retinitis pig-
mentosa (RP) characterized by the presence of crystals
in the corneal limbus, posterior pole of the eye, and
circulating lymphocytes. Clinically, progressive night
blindness and constriction of the visual fields occurs
around the 3d and 4th decade of life, followed by visual
loss rapidly progressing to legal blindness in the 5th or
6th decade. Multiple glistening intraretinal dots occur
over the fundus, associated with degeneration of the ret-
ina and sclerosis of the choroidal vessels (Bietti 1937).
Although BCD is felt to be rare worldwide, it accounted
for ∼3% (3/104 index patients) of all nonsyndromic RP
and for ∼10% of nonsyndromic autosomal recessive RP
in a recent series from Europe (F.L.M., unpublished
data). BCD also appears to be more common in indi-
viduals of Asian descent (Hu 1983; Kaiser-Kupfer et al.
1994), especially in those from China, where the gene
frequency has been estimated to be .005. Wilson et al.
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(1989) described, in the retina, crystals resembling cho-
lesterol or cholesterol esters. Complex lipid inclusions
also occur in the cornea, conjunctiva, fibroblasts, and
circulating lymphocytes, suggesting that BCDmay result
from a systemic abnormality of lipid metabolism. More
recently, histopathologic studies of the eye demonstrated
advanced panchorioretinal atrophy, with crystals and
complex lipid inclusions seen in choroidal fibroblasts.
(Kaiser-Kupfer et al. 1994)
A number of findings point to the existence of systemic
abnormalities of lipid metabolism in BCD (Lee et al.
1999). Abnormally high levels of triglycerides and cho-
lesterol storage are seen in cultured cells from patients
with BCD, whereas metabolism of labeled fatty-acid pre-
cursors into n-3 PUFA is decreased in BCD. A deficiency
or dysfunction of a fatty-acid–binding protein could
cause decreased uptake and transfer between lipid pools.
In addition, deficient elongation and desaturation of
fatty-acid precursors could cause the deposit, in crys-
talline form, of lipids within disease cells. Lymphocytes
from patients with BCD have been shown to lack two
fatty-acid–binding activities (Lee et al. 1998), but the
relationship between the disease and these two absent
binding activities remains unclear, especially since the
disease is inherited as a single autosomal recessive trait.
To compliment the biochemical approach to defining
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Table 1
Summed Two-Point Linkage Results for BCD in All Families
MARKERS
(DISTANCEa)
LOD SCORE AT v p
Zmax v0 .01 .05 .1 .2 .3 .4
D4S3047 206.07 6.08 1.85 .47 .61 .37 .11 .61 .20
D4S3032 (4) 99.52 .59 1.45 1.31 .91 .46 .12 1.52 .07
D4S3051 (5) 101.09 .03 .96 1.14 .87 .50 .16 1.16 .09
D4S2921 (2) 1.04 2.37 2.69 1.97 1.32 .70 .21 2.70 .04
D4S426 4.81 4.66 4.08 2.60 1.66 .84 .25 4.81 .00
D4S2930 (1)  99.15 2.01 2.75 1.82 1.26 .66 .20 2.75 .06
D4S2688 3.97 3.84 3.31 2.70 1.63 .81 .24 3.97 .00
D4S2283 98.66 1.61 2.37 2.20 1.43 .66 .16 2.37 .05
D4S1652 99.55 1.13 1.94 1.85 1.24 .61 .15 1.97 .06
D4S2299 5.31 5.14 4.51 3.76 2.34 1.18 .39 5.31 .00
a Distance (in cM) from preceding marker.
the gene causing BCD, linkage analysis of this disease
in 10 families was carried out. Linkage was established
with markers on chromosome 4q35-4qtel, including
D4S426 (maximum LOD score [Zmax] 4.81; recombi-
nation fraction [v] 0), D4S2688 ( ; ),Z p 3.97 vp 0max
and D4S2299 ( ; ).Z p 5.31 vp 0max
Initially, a genomewide linkage screen for the BCD
locus was performed in 10 families of Chinese (033001
and 033014), Japanese (033002–03307), and European
(033010 and 033011) ethnic origin. Samples from four
additional affected individuals were included in homo-
zygosity mapping. Forty-nine individuals, 16 of whom
were affected and 33 of whom were unaffected, were
enrolled in this study. This study was approved by the
National Eye Institute Institutional Review Board, and
the patients admitted to the study gave their informed
consent. Detailed ocular, medical, and family histories
were obtained from each available family member. The
affected family members underwent a complete physical
examination. Fundus photography was performed on all
affected patients. Clinical diagnosis was based both on
the presence of superficial corneal crystals seen at the
corneoscleral limbus (by slit-lamp biomicroscopy) and
of abundant small sparkling yellow white crystals in the
posterior pole and on atrophy of retinal pigment epi-
thelium, sclera, and choroid (on funduscopic examina-
tion). Diagnosis was confirmed by the presence of lipid
inclusions in lymphocytes in families 1, 10, and 11.
DNA was extracted either directly from blood or from
transformed lymphoblastoid cell lines, by standard phe-
nol-chloroform protocols (Smith et al. 1989). A ge-
nomewide scan was performed with 106 fluorescently
labeled microsatellite markers (ABI Prism LinkageMap-
ping Set, version 2). For multiplexing PCR, each reaction
was carried out in a 5-ml mixture containing 40 ng of
genomic DNA, different combinations of 10 mM fluo-
rescent dye–labeled primer pairs, 10# GeneAmp PCR
Buffer II, 250 mMGeneAmp dNTP mix, 2.5 mMMgCl2,
0.2 U Taq DNA (AmpliTaq Gold Enzyme). Amplifica-
tion was done by using an 800 Catalyst Molecular Bi-
ology Labstation (PE Biosystems). Initial denaturation
was 12 min at 95C; followed by 10 cycles of 15 s at
94C, 15 s at 55C, and 30 s at 72C; then 20 cycles of
15 s at 89, 15 s at 55, and 30 s at 72; and, last, with
a 20-min extension cycle at 72C and final hold at 4C.
PCR products from each DNA sample were pooled and
mixed with a loading cocktail containing formamide,
Gs-400HD ROX standards (PE Biosystems), and load-
ing dye. The product was loaded onto 5% acrylamide
gel and run in an ABI 377 Prism DNA Sequencer. The
data were analyzed by ABI GENESCAN 3.1 and ABI
GENOTYPER 2.1 software (PE Biosystems). Two in-
dependent individuals who were blinded to each other
and to any phenotypic or family information read all
gels, with conflicts resolved by a third independent
reader. Data producing conflicts that could not be un-
ambiguously resolved were discarded or, in an area of
interest, repeated. Family relationships were confirmed
by observation of Mendelian inheritance with 382 au-
tosomal microsatellite markers from the ABI Linkage
Mapping Set MD-10.
Initially a genomewide linkage screen was carried out
using the ABI Medium Density Marker panel, with mi-
crosatellite markers distributed at an average of 10-cM
intervals. Homozygosity mapping with pooled affected
and unaffected siblings from each ethnic group gave no
suggestion of linkage, over all chromosomes. Standard
two-point linkage analysis was then carried out for all
markers. Two-point linkage analysis was performed us-
ing the MLINK program of the LINKMAP program
package, version 5.1 (Lathrop and Lalouel 1984), Zmax
scores were calculated using ILINK, and LINKMAPwas
used for multipoint analysis. BCD was analyzed as a
fully penetrant autosomal recessive trait. The gene fre-
quency of BCDwas set at .005 (Hu 1983). For screening,
equal allele frequencies were assumed for all markers.
When an initial LOD score of 3.6 was obtained with
D4S426 at , five additional markers from the Ge´-vp 0
Figure 1 Haplotypes for 10 markers from 4q35-4qtel, for 10 families with BCD. Marker order is shown to the left of each generation.
Shading indicates haplotypes, with alleles of uncertain origin shaded to maximize the critical region. Families 2, 5, and 7 are all first-cousin
matings, and, in these families, haplotypes consistent with identity by descent are shaded in solid black.
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ne´thon database (D4S3047–4 cM–D4S3032–5 cM–
D4S3051–2 cM–D4S2921/D4S426–1 cM–D4S2930)
and four polymorphic markers, positioned immediately
telomeric of D4S2930, by physical mapping on the Stan-
ford Human Genome Center YAC contig (D4S2688,
D4S2283, D4S1652, and D4S2299), were analyzed to
confirm the linkage. To our knowledge, these are the
most telomeric polymorphic markers currently identified
on chromosome 4q.
For fine mapping, the appropriate ethnic-specific allele
frequencies for markers D4S426, D4S3047, D4S3032,
D4S3051, D4S2921, D4S2930, D4S2688, D4S2283,
D4S1652, and D4S2299were approximated on the basis
of 14 Chinese, 12 Japanese, and 15 European unrelated
and unaffected individuals (28, 24, and 30 chromo-
somes, respectively). As seen in table 1, two-point link-
age analysis gave evidence for linkage to markers on
chromosome 4q35, with Zmax values of 4.81 with
D4S426, at , 3.97 with D4S2688, at , andvp 0 vp 0
5.31 with D4S2299, at . Suggestive LOD scoresvp 0
were also seen with other markers in the region, in-
cluding D4S2921 ( ; ), D4S2930Z p 2.70 vp .04max
( ; ), and D4S2283 ( ;Z p 2.75 vp .06 Z p 2.37max max
). These markers, however, showed obligate re-vp .05
combinants.Multipoint linkage analysis carried outwith
overlapping sets of three markers from the Ge´ne´thon
database confirmed linkage to this region ( )Z p 5.3max
located 4 cM telomeric of marker D4S2930 (data not
shown). Multipoint analysis carried out with VITESSE,
using, in this interval, all mapped markers from the Ge´-
ne´thon database simultaneously but discounting con-
sanguinity loops, also confirmed linkage ( )Z p 3.36max
in the same region. Heterogeneity was examined using
both the two-point linkage data from D4S3051,
D4S2921, D4S426, and D4S2930 and the multipoint
linkage data from these markers. Neither the M test
for the three ethnic groups nor the admixture test
(HOMOG) gave significant support for genetic hetero-
geneity. The admixture test was also performed for any
marker in the genome screen with a at anyZ 1 1max
recombination fraction. No significant evidence was ob-
tained for linkage with or without heterogeneity to any
region outside chromosome 4q35-tel.
Visual inspection of the haplotypes for markers in this
region supported the linkage-analysis data (fig. 1). In
family 10, affected individuals 4 and 6 have inherited
the same parental haplotypes for markers D4S2921–
D4S2299, but a recombination event has taken place,
at D4S3047, in individual 4, with markers D4S3032 and
D4S3501 being uninformative. In family 14, affected
individual 4 and unaffected sibling 5 have inherited the
same parental haplotypes for markers D4S1652–
D4S3051, a result that excludes that part of the interval.
Although they have the same alleles for D4S2299, their
mother is not informative for this marker, so this does
not represent an obligate recombination event. She is
also homozygous for D4S426, so this marker does not
show an obligate recombination either. D4S2688 is not
excluded because the father, whose DNA is not available
for testing, could theoretically be uninformative at that
locus.
Families 033002, 033005, and 033007 are all first-
cousin matings, so markers closely linked to the BCD
locus are likely to be homozygous. In family 2, the
only markers in the region that are homozygous are
D4S3032, D4S426, D4S2688, and D4S2299. Because
DNA samples are not available from all individuals who
make up the consanguinity loop, the origin of these al-
leles cannot be traced unambiguously, and the presence
of closely linked flanking markers suggests that this
might represent identity by state rather than identity by
descent. In family 5, individual 3 is not homozygous for
markers D4S3047 and D4S3032, a result that limits the
candidate region to the area telomeric of D4S3032. Sim-
ilarly, in family 7, individual 3 is not homozygous for
D4S3047.
The explanation most consistent with the aforemen-
tioned data is that the BCD locus resides on chromosome
4q, at a point telomeric of marker D4S1652. Although
it remains a formal possibility, it seems unlikely that
these results with highly significant two-point and mul-
tipoint LOD scores are spurious, produced by a fortu-
itous combination of alleles. Markers in the D4S3051–
D4S1652 region recombine with BCD in families
033002 (Japanese) and 033014 (Chinese). Recently, an
autosomal dominant retinopathy phenotypically similar
to BCD has been described (Richards et al. 1991), sug-
gesting that more than one genetic locus might exist for
the BCD phenotype. However, although they certainly
do not exclude locus heterogeneity, these data do not
statistically support it. Thus, whereas locus heteroge-
neity with one locus in the D4S3051–D4S1652 interval
also remains a formal possibility, our current results sug-
gest a single BCD locus telomeric of D4S1652. Although,
without having identified a distal flanking marker, it is
difficult to estimate the size of this interval, within 8 cM
the multipoint LOD scores drop by 1. This telomeric
region has not been mapped, but if the properties and
gene density were found to be similar to the genome
averages, this might correspond to bp contain-68# 10
ing 100–300 genes. Studies to refine this interval and to
identify candidate genes in this chromosomal region are
currently under way.
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